Mimulus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.35 Cr
as on 27-12-2024
- Paid Up Capital ₹ 3.35 Cr
as on 27-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 Cr
as on 27-12-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 55.85%
(FY 2023)
About Mimulus Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.35 Cr and a paid-up capital of Rs 3.35 Cr.
The company currently has active open charges totaling ₹7.00 Cr.
Santhanalakshmi, Sekar Kothandaraman, Venkatarayalu Kumarakrishnan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24295PY2015PTC002977
- Company No.
002977
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mimulus Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhanalakshmi  | Director | 19-Jun-2015 | Current |
| Sekar Kothandaraman | Director | 10-Feb-2023 | Current |
| Venkatarayalu Kumarakrishnan | Director | 07-Oct-2016 | Current |
| Kumarakrishnan Janeshwar | Director | 23-Jun-2018 | Current |
Financial Performance of Mimulus Laboratories.
Mimulus Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mimulus Laboratories?
Unlock access to Mimulus Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jul 2023 | ₹3.00 Cr | Open |
Others Creation Date: 21 Feb 2022 | ₹4.00 Cr | Open |
How Many Employees Work at Mimulus Laboratories?
Unlock and access historical data on people associated with Mimulus Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mimulus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mimulus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
